A novel polymerase chain reaction method was developed to preferentially amplify a segment of DNA containing a base substitution mutation. This technique uses a pair of dideoxynucleotide-labeled oligonucleotides (18 mers) of normal sequences as blockers located between the two primers. By virtue of a subtle difference in the melting temperature between the blocker-normal DNA and blocker-mutant DNA hybrids, the method allows preferential amplification of the mutant DNA. We used the human N-ras gene as a model. Two different types of N-ras mutations could be effectively amplified when they were present with an excess amount of normal DNA at a ratio of 1:10 3
INTRODUCTION
It is believed that the combination of several mutations at different loci within a cell is required for the development of human cancer (1) . Because mutant cells bearing only one such mutation do not show a malignant phenotype, they cannot be identified by an ordinary positive selection technique in in vitro cell cultures. Consequently, the frequency of such cells in vivo has not been documented.
Using the recently developed polymerase chain reaction (PCR) technique, three methods have been reported to detect rare activated ras genes in the presence of a large number of nonmutant cells (2) (3) (4) . These methods use specially designed primers to detect a specific base change at a specific base of a specific codon. Kumar et al. (2) used mismatched primers designed to contain part of the sequences of certain restriction enzymes to recognize mutant ras alleles in the PCR-amplified products. The G-to-A transition at the second base of codon 12 of the H-ras or K-ras gene creates a new restriction fragment length polymorphism site, and the assay could detect one such mutant cell in the presence of 10 4 normal cells. Haliassos et al. (3) developed a similar assay but in a reversed sense, namely, the K-ras allele bearing normal codon 12 could be digested, whereas base change mutations at the first or second base of codon 12 resulted in loss of the Msp I restriction site. The sensitivity for the detection of mutant alleles was on the order of 10~4. However, the assay cannot detect mutations at other bases, e.g., in codon 13. Ehlen and Dubeau (4) used primers with 3' ends complementary to specific base changes for selective amplification of mutant alleles and reported that the detection sensitivity was on the order of 10~7.
Although it has been shown that certain chemical carcinogens induce unique patterns of base changes at a specific site of ras genes in animal tumors, human tumors were found to contain various kinds of base changes in different codons leading to ras gene activation (5) . Therefore, as far as ras gene mutations in human somatic cells are concerned, the application of these methods is considerably restricted.
Here we describe a novel PCR method designed to overcome this limitation. This technique uses a pair of complementary oligonucleotides (18 mers, to serve as blockers) located between the two primers (24 mers) (Fig. 1) . The blockers used in the present study consisted of normal base sequences of the human N-ras gene including codon 12, with the 3' ends labeled with dideoxynucleotides to prohibit their elongation by DNA polymerase. Under the appropriate annealing and extension conditions, the blockers hybridize to normal alleles more preferentially than to mutated alleles bearing base change mutations because of the presence of a mismatched base pair in the blocker-mutant DNA hybrids. Consequently, DNA replication proceeds less smoothly in normal DNA than in mutant DNA. As a result, selective PCR amplification of mutant alleles could be achieved. 
METHODS
A pair of oligonucleotides of 24 mers was synthesized according to the published sequences (6) and used as primers in amplifying the N-ras exon 1. Another pair of complementary oligonucleotides of 17 mers including the N-ras codon 12 was synthesized, followed by the addition of one sequence-matched dideoxynucleotide at the 3' ends by terminal deoxynucleotidyltransferase (7). Various amounts of genomic DNA were subjected to PCR amplification in 10 fiL of a mixture containing 0.2 /tM each of the primers PN12-1 and PN12-2, 4 /*M each of the blockers BN12-1 and BN12-2, 125 /*M each of four dNTPs, 10 mM Tris-HCl (pH 8.4), 50 mM KC1, 1.5 mM MgCl 2> 100 /ig/mL of gelatin, and 0.2 units of Taq DNA polymerase (PerkinElmer Cetus, Norwalk, CT). The thermal cycle profile consisted of two steps instead of the ordinary three, namely, 94°C (30 s) and 58°C (60 s) for 35 cycles followed by a final cycle at 58°C for 10 min. The ordinary extension temperature of 72°C was avoided here because under such high-temperatures blockers of 18 mers can no longer remain hybridized to both normal and mutant DNA and hence no preferential amplification of the mutant allele could be achieved. Two microliters of the PCR products were subjected to 8% polyacrylamide gel electrophoresis and the gel was stained with ethidium bromide. The base squences of the primers and blockers were as follows. Primers: PN12-1, 5'-AATGACTGAGTACAAACTGGTGGT-3'; and PN12-2, 5'-TCCTCTATGGTGGGATCATATTCA-3'. Blockers: BN12-1, 5'-AGCAGGTGGTGTTGGGAA*-3'; and BN12-2, 5'-TTCCCAACACCACCTGCT*-3'. The bases with asterisks represent dideoxynucleotides.
For single strand conformation polymorphism (SSCP) analysis (8), blocker-PCR amplification was performed in a two times larger volume (total = 20 /xL) while the concentration of reagents remained the same as described above. The products were diluted to 10~2 or 10~3 and 1 /*L was used for labeling by PCR in 10 tiL of mixture containing 10 mM Tris-HCl (pH 8.4), 50 mM KC1, 1.5 mM MgCl 2 , 100 /ig/mL gelatin, 10 /tM each of four dNTPs, 0.2 pM each of the primers PN12-1 and PN12-2, 1 /*L of [a-
32 P]dCTP (1.1 X10" Bq/ml) and 0.2 units of Taq DNA polymerase. Thirty-five cycles of PCR were performed with 95°C denaturation (30 s), 58°C annealing (60 s), and 72°C extension (60 s) in an automated thermal cycler (MJ Research, Inc.). The PCR-amplified products were diluted 100-fold with 0.1% SDS and 10 mM EDTA followed by 1:1 dilution with 95 % formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol. After denaturation by heating at 95 °C for 10 min, the samples were loaded onto a 12% polyacrylamide gel (30:1 ratio of acrylamide to methylene-few acrylamide, 60 X 20 x 0.03 cm, 0.5 cm per lane) containing 90 mM Trisborate (pH 8.3), and 2 mM EDTA. Electrophoresis was carried out at 8 C under 30 W constant power for 5 hr. The gel was dried on filter paper and exposed to X-ray film at -80°C for about 12 hr with an intensifying screen.
The human B-cell lines used were established after in vitro transformation of normal lymphocytes with Epstein-Barr (EB) virus. DNA of skin fibroblasts was derived from a human skin culture at passage 3. Four human tumor cell lines were obtained from the Japanese Cancer Research Resource Bank, Tokyo. Molt-4 (lymphatic leukemia), PA-1 (teratocarcinoma), and THP-1 (monocytic leukemia) contain the base change mutations TGT, GAT, and GAT, respectively, at codon 12 of the N-ras gene (normally GGT).
KG-1 (lymphatic leukemia) has no mutation in exon 1 of the N-ras gene (confirmed by direct sequencing). Figure 2 -A shows the results of successful PCR amplification of 109-bp DNA fragments for both normal and mutant N-ras genes without the blockers (starting material: 12.5 ng of DNA, 35 cycles). When an excess amount of the blockers was present, however, visible bands were observed only for tumor cell lines bearing base change mutations (Molt 4, PA-1 and THP-1) but not for others, namely three EB-virus-transformed cell lines, one normal skin fibroblast cell line, and one leukemic cell line KG-1, none of which carries a mutant allele (Figure 2-B) . Successive dilutions of DNA showed that the presence of normal or mutant DNA equivalent to a few cells, viz., 12.5 pg, could be detected when two rounds of 35 cycles of PCR amplification were performed without the blockers (Figure 3-A) . On the contrary, when the blockers were present, mutant DNA (Figure 3 -B, middle six lanes) but not the normal DNA (Figure 3 the same two rounds of PCR amplification, artificial mixtures of mutant and normal DNA with different ratios were examined. It was found that mutant DNA equivalent to a few cells could be detected in the presence of a large amount of normal DNA corresponding to an excess of 10 3 ( Figure 3 -B, right six lanes). To confirm that the blocker-PCR-amplified products contained mutant DNA, PCR-SSCP analysis was undertaken. For this purpose, the first round of blocker-PCR amplification was performed in a two times larger volume to handle a two times larger amount of DNA. Subsequently, the products were subjected to a second round of amplification without blockers but in the presence of [a-32 P]-dCTP for labeling. The results for the SSCP analysis are shown in Figure 4 . When 25 ng of DNA from B-cell lines (normal N-ras genes) were used for the first blocker-PCR amplification, three bands were observed (open circles, left two lanes in Figure 4) . On the contrary, when 2.5 pg of DNA, equivalent to a single cell, from tumor cell lines bearing a mutant N-ras allele was used, two additional bands were observed (closed circles, middle two lanes in Figure 4) . When the mixtures of DNA from N-ras mutant cell lines and from B-cell lines were examined, the presence of mutant DNA was detectable when 2.5 pg of DNA from mutant cell lines and 25 ng of DNA from B-cell lines were mixed (a dilution ratio of 10~4; right two lanes in Figure 4) . The results show that the sensitivity of the assay could be improved by 10 times when one round of blocker PCR is followed by SSCP compared with two rounds of blocker PCR.
RESULTS

DISCUSSION
Compared with the published methods using mismatched primers (2-4), the present blocker-PCR method has wider applications for the detection of rare mutant DNA since the target site for mutation detection is not restricted to the specific base(s). In fact, two different base change mutations at codon 12 of the N-ras gene could be equally amplified in the presence of the blockers (Figure 2-B) . With the combination of SSCP analysis, the present assay could detect a mutant cell in the presence of a 10 4 times excess amount of cells with normal N-ras genes. In addition, this method is suitable for the detection of rare mutations not only in ras genes-most of which are known to carry base change mutations at codons 12, 13, or 61-but also in the p53 gene, in which mutations are found to occur at different codons in several hotspot regions (9) . It may also have a potential for the cloning of rare transcripts from certain gene families that have highly expressed members.
One of the fundamental requirements of the blocker-PCR method is that the melting temperatures of the primers have to be set distinctively higher than those of the blockers. In the present study, oligonucleotides of 24 mers and 18 mers were used successfully as primers and blockers, respectively, for this purpose. In addition, a careful determination of the best annealing conditions is crucial since a small difference such as 2°C may affect the results.
As for the blockers, their extension by Taq polymerase has to be prohibited or the blockers will serve as primers to generate artifactual full-sized primer-primer DNA fragments. Although we used matched oligomers as blockers with the 3'ends labeled with sequence-matched dideoxynucleotides, 3'-end mismatched oligomers may work as well if they are appropriately designed so that false elongation starting from the mismatched site (10) may be avoided.
The combination of two rounds of blocker PCR and SSCP was expected to improve further the sensitivity. However, the results revealed abundant amplification of part-length products (T. Seyama, unpublished observations). Such artifactual products were recognized frequently after a single round of blocker PCR, as shown in Figure 3 . Introduction of a pair of internally located primers in the second round of blocker PCR may overcome this limitation.
